Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

China

Risk factors for medical device-related pressure injury in ICU patients: A systematic review and meta-analysis

Ling Gou, Zhiqin Zhang, Yongde A.

Who behaves more pro-environmental in the national parks: A comparison of the tourist and the hiker

Qing Zhang, Huazhen Sun, Xiasui Peng, Qiuyan Lin

Nitrogen and phosphorus losses via surface runoff from tea plantations in the mountainous areas of Southwest China

Xingcheng Huang, Darong Zhen, [ ... ], Taiming Jiang

Cash flow management and its effect on firm performance: Empirical evidence on non-financial firms of China

Fahmida Laghari, Farhan Ahmed, María de las Nieves López García

Chairman’s Communist Party of China member status and targeted poverty alleviation: Evidence from China

Jian Xie, Ruirui Gu, [ ... ], Ruian Yu

Genome characterization based on the Spike-614 and NS8-84 loci of SARS-CoV-2 reveals two major possible onsets of the COVID-19 pandemic

Xiaowen Hu, Yaojia Mu, [ ... ], Jiaming Zhang

Diagnostic accuracy of the Copenhagen Index in ovarian malignancy: A meta-analysis

Huiling Liu, Shouye Ma, [ ... ], Xiazi Nie

The incentive role of media companies’ executive compensation system in transformation and upgrading: Evidence from listed media companies in China

Wancheng Yang, Jinwen Xu, [ ... ], Shaofeng Wang

Grandparental childcare and second births in China

Jing Zhang, Tom Emery

Construction enterprises’ green financing efficiency and its influencing factors including internal and external: Based on four-stage DEA model

Yaguai Yu, Panyi Shen, [ ... ], Fangyuan Chen

Geographical specific association between lifestyles and multimorbidity among adults in China

Peixi Rong, Yukui Chen, [ ... ], Leilei Pei

Housing investment and family entrepreneurship: Evidence from China

Xiaobing Huang, Liu Min, [ ... ], Syed Zaheer Abbas

A trial-based cost-utility analysis of sugemalimab vs. placebo as consolidation therapy for unresectable stage III NSCLC in China

Wei Li, Li Wan

Advertisement

Create a weekly email alert for: China

You can change these options by clicking profile then "Alerts and Notifications"